[Policy Recommendations] Improving Patient Access to Genomic Cancer Medicine (August 10, 2023)
date : 8/10/2023
Tags: NCDs, Precision Cancer Medicine
Health and Global Policy Institute (HGPI) has presented a policy recommendation paper regarding the improvement of patient access to Genomic Cancer Medicine.
Executive summary
- Genomic Cancer Medicine was viewed as an advanced form of medical treatment when Comprehensive Genomic Profiling (CGP; or cancer gene panel tests) was granted health insurance coverage in 2019. Since then, people serving in clinical settings have accumulated experience handling this form of treatment. We are now at a stage to make Genomic Cancer Medicine a form of technology from which anyone should be able to benefit. To achieve this, we should improve patient access to deliver Genomic Cancer Medicine more broadly to the public.
- From the perspective of patient access opportunities, policy challenges with respect to delivering Genomic Cancer Medicine may be sorted into three categories:
A: Constraints related to human resources in medicine
B: Constraints related to genetic testing
C: Constraints related to geographic factors or information
We must take wherever possible actions to address each issue one by one, and expand opportunities for patients to access Genomic Cancer Medicine.
- Based on these understandings, HGPI offers the following recommendations:
RECOMMENDATION I: Streamline operations and secure human resources
In view of the further spread of genomic cancer medicine, streamline operations thoroughly, and adopt systems to secure human resources commensurate with workloads.
RECOMMENDATION II: Review genetic testing practices including how tests are performed
Based on the accumulated clinical experiences, revise the genetic tests and related practices to meet the needs of those serving in clinical settings, and to suit the characteristics of each type of cancer.
RECOMMENDATION III: Improve patient access to testing centers and clinical trials
While paying attention to the constraints and disparities related to geographic factors/information, make drastic improvements to patient access to testing centers and clinical trials.
As for precision cancer medicine, HGPI launched an initiative in FY2021 (“Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society”), and has made expert hearings and conducted surveys to examine the issue. Based on our findings, we offered comprehensive policy recommendations in September 2022.
For the second phase of this project, we compiled this policy recommendation paper, based on additional, expansive surveys and hearings with our focus on measures for better patient access to Genomic Cancer Medicine.
HGPI strongly hopes these recommendations will be utilized in developing further policy measures for Genomic Cancer Medicine, and patient-centered healthcare.
For details, please see the PDFs linked below.
Sponsors (in alphabetical order):
Bayer Yakuhin, Ltd.
Chugai Pharmaceutical Co., Ltd.
Janssen Pharmaceutical K.K.
MSD K.K.
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)